PJ view: Patients deserve a regulatory system built to keep them safe as oral semaglutide launches Regulators have taken welcome steps to tackle counterfeit weight-loss medicines, but patients cannot be left to police this market alone.…
The pharmacist’s role in optimising care for adults with trigeminal neuralgia This article offers an overview of the clinical features and pharmacological management of trigeminal neuralgia, as well as ways in which pharmacists can provide holistic care for patients.…
Pharmacist Support counselling sessions increase by more than half in 2025 Pharmacist Support’s latest impact report also revealed that referrals to counselling for pharmacists increased by nearly one-third in 2025.…
The patient information leaflet: is it really working for patients? How a broader approach to medicines information will encourage safer use and better understanding for patients.…
NICE draft guidance recommends finerenone for type of chronic heart failure The National Institute for Health and Care Excellence noted that indirect comparison suggests that finerenone may work as well as spironolactone in treating heart failure with mildly reduced ejection fraction in adults.…
Health news round-up: vaccination, testosterone and neighbourhood health The Pharmaceutical Journal’s weekly summary of the important developments in pharmacy and health news you may have missed.…
Stopping antipsychotics in patients with dementia reduces risk of fracture and delirium The study’s lead author said the “findings provide reassurance” that stopping long-term antipsychotic treatment when no longer needed prevents harms.…
Coroner raises concerns over lack of national guidance on prescribing for hepatitis B reactivation A patient died from complications from reactivation of hepatitis B, after the supply of viral reactivation prophylaxis was inadvertently discontinued.…
Pharmacists having to procure their own pandemic PPE ‘a major failure in planning’, finds COVID-19 inquiry The COVID 19 inquiry report described the government's personal protective equipment distribution plans as “inadequate”.…
ADHD medicines prescriptions rose again in 2025 More than 991,000 items of lisdexamfetamine were prescribed in NHS primary care in 2025, which is a 36% increase compared with 2024, according to Care Quality Commission data.…
